Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Tesaro.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Tesaro
United_States_of_America Flag

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

JEMPERLI was generated by AnaptysBio using its proprietary somatic hypermutation (SHM) antibody platform and subsequently developed by TESARO, Inc., now a part of GSK, under a collaboration agreement.


Lead Product(s): Dostarlimab

Therapeutic Area: Oncology Product Name: Jemperli

Highest Development Status: ApprovedProduct Type: Large molecule

Recipient: AnaptysBio

Deal Size: $240.0 million Upfront Cash: Undisclosed

Deal Type: Collaboration August 17, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY